Reverse Engineering of Ewing Sarcoma Regulatory Network Uncovers PAX7 and RUNX3 as Master Regulators Associated with Good Prognosis

SIMPLE SUMMARY: Ewing Sarcoma is a rare cancer that, when localized, has an overall five-year survival rate of 70%. Patients with metastasis have a five-year survival rate of 15 to 30%. Early analysis of patient prognosis can be crucial to provide adequate treatment and increase chances of survival....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Ribeiro-Dantas, Marcel da Câmara, Imparato, Danilo Oliveira, Dalmolin, Matheus Gibeke Siqueira, de Farias, Caroline Brunetto, Brunetto, André Tesainer, da Cunha Jaeger, Mariane, Roesler, Rafael, Sinigaglia, Marialva, Siqueira Dalmolin, Rodrigo Juliani
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8070584/
https://ncbi.nlm.nih.gov/pubmed/33924679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13081860
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars